Publications

Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD  (2022)

Authors:
Dinoto, Alessandro; Sechi, Elia; Ferrari, Sergio; Gajofatto, Alberto; Orlandi, Riccardo; Solla, Paolo; Maccabeo, Alessandra; Maniscalco, Giorgia Teresa; Andreone, Vincenzo; Sartori, Arianna; Manganotti, Paolo; Rasia, Sarah; Capra, Ruggero; Mancinelli, Chiara Rosa; Mariotto, Sara
Title:
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD
Year:
2022
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
Elettronico
Referee:
Name of journal:
MULTIPLE SCLEROSIS AND RELATED DISORDERS
ISSN of journal:
2211-0348
N° Volume:
58
Number or Folder:
103424
Page numbers:
1-4
Keyword:
AQP4; MOG; MOGAD; NMOSD; SARS-CoV-2; vaccination
Short description of contents:
Post-vaccination disease relapses have been reported in patients with MOGAD and AQP4-IgG+NMOSD. In this retrospective multicenter Italian study we assessed the frequency of relapses after SARS-CoV-2 vaccination. We included 56 cases: MOGAD, 30; AQP4-IgG+NMOSD, 26. Vaccines received were BNT162b2-Pfizer-BioNTech in 42 patients and mRNA-1273-Moderna in 14 patients. Six patients had a history of SARS-CoV-2 infection; two of them experienced a post-infection disease relapse (MOGAD). The frequency of relapses within one month of SARS-CoV-2 vaccination was 4% (1/26) in the AQP4-IgG+NMOSD group and 0% in the MOGAD group. In these patients the potential benefits of vaccination overcome the risk of relapses.
Web page:
https://doi.org/10.1016/j.msard.2021.103424
Product ID:
125111
Handle IRIS:
11562/1058664
Last Modified:
November 15, 2022
Bibliographic citation:
Dinoto, Alessandro; Sechi, Elia; Ferrari, Sergio; Gajofatto, Alberto; Orlandi, Riccardo; Solla, Paolo; Maccabeo, Alessandra; Maniscalco, Giorgia Teresa; Andreone, Vincenzo; Sartori, Arianna; Manganotti, Paolo; Rasia, Sarah; Capra, Ruggero; Mancinelli, Chiara Rosa; Mariotto, Sara, Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD «MULTIPLE SCLEROSIS AND RELATED DISORDERS» , vol. 58 , n. 1034242022pp. 1-4

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share